- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Endocrinology
Volume 2012 (2012), Article ID 584807, 8 pages
Molecular Bases and Phenotypic Determinants of Aromatase Excess Syndrome
1Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Ohkura, Setagaya, Tokyo 157-8535, Japan
2Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City 206-8670, Japan
3Department of Pediatrics, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Shizuoka, Hamamatsu 431-3192, Japan
Received 9 July 2011; Revised 22 September 2011; Accepted 2 October 2011
Academic Editor: Rodolfo Rey
Copyright © 2012 Maki Fukami et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. Bhasin, “Testicular disorders,” in Williams Textbook of Endocrinology, H. M. Kronenberg, M. Melmed, K. S. Polonsky, and P. R. Larsen, Eds., pp. 645–699, Saunders, Philadelphia, Pa, USA, 11th edition, 2008.
- M. Shozu, S. Sebastian, K. Takayama et al., “Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene,” New England Journal of Medicine, vol. 348, no. 19, pp. 1855–1865, 2003.
- M. Demura, R. M. Martin, M. Shozu et al., “Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene,” Human Molecular Genetics, vol. 16, no. 21, pp. 2529–2541, 2007.
- M Fukami, M Shozu, S Soneda, et al., “Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 6, pp. E1035–E1043, 2011.
- G. Binder, D. I. Iliev, A. Dufke et al., “Dominant transmission of prepubertal gynecomastia due to serum estrone excess: Hormonal, biochemical, and genetic analysis in a large kindred,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 484–492, 2005.
- R. M. Martin, C. J. Lin, M. Y. Nishi et al., “Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3027–3034, 2003.
- A. Tilpakov, N. Kalintchenko, T. Semitcheva, et al., “A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, pp. 4184–4190, 2005.
- C. A. Stratakis, A. Vottero, A. Brodie et al., “The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant p450 aromatase gene transcription,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 4, pp. 1348–1357, 1998.
- S. Sebastian and S. E. Bulun, “Genetics of endocrine disease: a highly complex organization of the regulatory region of the human CYP19 (Aromatase) gene revealed by the human genome project,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4600–4602, 2001.
- S. E. Bulun, K. Takayama, T. Suzuki, H. Sasano, B. Yilmaz, and S. Sebastian, “Organization of the human aromatase P450 (CYP19) gene,” Seminars in Reproductive Medicine, vol. 22, no. 1, pp. 5–9, 2004.
- M. Demura, S. Reierstad, J. E. Innes, and S. E. Bulun, “Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene,” Reproductive Sciences, vol. 15, no. 10, pp. 1044–1053, 2008.
- N. Harada, T. Utsumi, and Y. Takagi, “Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11312–11316, 1993.
- E. R. Simpson, “Aromatase: biologic relevance of tissue-specific expression,” Seminars in Reproductive Medicine, vol. 22, no. 1, pp. 11–23, 2004.
- E. E. Wallach and C. R. Garcia, “Familial gynecomastia without hypogonadism: a report of three cases in one family,” The Journal of Clinical Endocrinology and Metabolism, vol. 22, pp. 1201–1206, 1962.
- G. D. Berkovitz, A. Guerami, T. R. Brown, P. C. MacDonald, and C. J. Migeon, “Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids,” The Journal of Clinical Investigation, vol. 75, no. 6, pp. 1763–1769, 1985.
- W. Gu, F. Zhang, and J. R. Lupski, “Mechanisms for human genomic rearrangements,” Pathogenetics, vol. 1, article 4, 2008.
- M. B. Yilmaz, A. Wolfe, Y. H. Cheng, C. Glidewell-Kenney, J. L. Jameson, and S. E. Bulun, “Aromatase promoter I.f is regulated by estrogen receptor alpha (ESR1) in mouse hypothalamic neuronal cell lines,” Biology of Reproduction, vol. 81, no. 5, pp. 956–965, 2009.
- J. E. Mercer, D. J. Phillips, and I. J. Clarke, “Short-term regulation of gonadotropin subunit mRNA levels by estrogen: studies in the hypothalamo-pituitary intact and hypothalamo-pituitary disconnected ewe,” Journal of Neuroendocrinology, vol. 5, no. 5, pp. 591–596, 1993.
- D. C. Alexander and W. L. Miller, “Regulation of ovine follicle-stimulating hormone β-chain mRNA by 17β-estradiol in vivo and in vitro,” Journal of Biological Chemistry, vol. 257, no. 5, pp. 2282–2286, 1982.
- T. R. Kumar, Y. Wang, N. Lu, and M. M. Matzuk, “Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility,” Nature Genetics, vol. 15, no. 2, pp. 201–204, 1997.